ESGCT and ISSCRCongress, 17 - 22October 2016

TUESDAY18OCTOBER 2016
09:00-15:30 / Commercialisation and Clinical Trial Workshop
9:00 – 12:30
Detailed program to follow / Stem Cell Clonality Meeting
Starts on Monday
9:00 – 12:00
Click here for details / Education Session
09:30 – 15:30
Detailed program to follow / Public Day
9:30 – 15:30
Detailed program to follow
Molmed workshop
14:00 – 15:30
Program TBC
16:00-17:00 / ESGCT/ ISSCR 2016 OPENING:Nathalie Cartier, Luigi Naldini, ABCD, ISSCR
Opening Keynote– Hans Clevers
BlueBirdBio
17:00-19:00 / ESGCT/ ISSCRPLENARY SESSION 1: Neural Diseases: modelling, reprogramming and transplantation in brain and retina
Fred Gage, Masayo Takahashi, Malin Parmar, Paul Tésar
Auditorium
RegenX bio
19:00-20:00 / WELCOME RECEPTION
20:00-22:00 / BOARD MEETING
WEDNESDAY 19OCTOBER 2016
08:30-10:30 / ESGCT/ ISSCRPLENARY SESSION 2: Hematopoietic Stem Cells: from biology to clinical applications
John Dick, Leonard Zon, Luigi Naldini, Marina Cavazzana
Auditorium
Genethon
10:30-11:00 / COFFEE BREAKPalazzo Congressi
11:00-12:30 / S1a: Haematopoietic Stem Cells and Homeostasis
Emanuelle Passegue
Mick Milson
Or 1, Or 2 / S1b: Eye Stem Cell and Gene Therapy
Athena Vision
Graziella Pellegrini
Deniz Dalkara
Or 1, Or 2 / S1c: Central Nervous System Gene Therapy
Lysogene
Alessandra Biffi
Shin-ichi Muramatsu
Or 1, Or 2
12:30 – 14:00 / LUNCH Palazzo Congressi
14:00-16:00 / ESGCT/ ISSCRPLENARY SESSION 3: Skeletal and cardiac muscle stem cells: from biology and reprogramming to clinical applications
In memoriam Paolo Bianco
Christine Mummery, Mauro Giacca, Michael Laflamme, Luis Garcia
Auditorium
16:00-16:30 / COFFEE BREAKPalazzo Congressi
16:30-18:30 / S2a: Imaging stem cells dynamics
Valentina Greco
Timm Schroeder
Or 1, Or 2, Or3, Or4 / S2b: Stem Cell Based neural disease modelling
Giuseppe Testa
Angel Raya
Or 1, Or 2, Or3, Or4 / S2c: Cardiovascular Gene and Cell Therapy
Seppo Ylä- Herttuala
Andy Baker
Or 1, Or 2, Or3, Or4 / S2dImmunology/ Cancer Immuno Gene Therapy I
David Klatzman
Inder Verma
Wasseem Kasim
Or3, Or4
18:30-20:30 / POSTER SESSION 1
20:00-23:00 / SPEAKER DINNER
THURSDAY 20 OCTOBER 2016
08:00-10:00 / ESGCT/ ISSCRPLENARY SESSION 4: Cancer Immuno – Gene Therapy
Gianpietro Dotti, Stanley Riddell, Carl June, Chiara Bonini
Oxford Biomedica
Auditorium
10:00-10:30 / COFFEE BREAKPalazzo Congressi
10:30-12:30 / S3a: Organoids
Sergiu Pasca
David Tuveson
Or 1, Or 2, Or3, Or4 / S3b: MSC Gene and Cell Therapy
Wilfred Daelemans
Willem Fibbe
Or 1, Or 2, Or3, Or4 / S3c: In vivo Gene Therapy
Federico Mingozzi
Kathy High
Sabrina Triffault
Or 1, Or 2, Or3
12:30- 14:00 / LUNCHPalazzo Congressi
14:00-16:00 / S4a: Cancer Stem Cells
Michael Clarke
Dominique Bonnet
Or 1, Or 2, Or3, Or4 / S4b: Ex Vivo HSC based Gene and Cell therapy
Bobby Gaspar
Cynthia Dunbar
Or 1, Or 2, Or3, Or4 / S4c: DNA based gene transfer and integration studies
Ricardo Cortese
Jim Wilson
Or 1, Or 2, Or3, Or4
16:00-16:30 / COFFEE BREAKPalazzo Congressi
16:30-18:30 / ESGCT/ ISSCRPLENARY SESSION 5: New Technologies: targeted genome and epigenome editing, new vector design, organoids
Editas
Angelo Lombardo, Feng Zhang, Melissa Little, Pierre Vanderhaeghen
Auditorium
18:40-20:00 / POSTER SESSION 2
Palazzo Affari
20:00- / GALA DINNER
Mercato Centrale
FRIDAY 21OCTOBER 2016
09:00-10:30 / S5a: RNA Based Gene Transfer and Integration studies
Christof von Kalle
Luca Biasco
Or 1, Or 2, / S5b: Genome editing and Gene Correction
Toni Cathomen
Charles Gersbach
Or 1, Or 2, / S5c: Cancer Gene Therapy
Ramon Alemany
Yasutomo Nasu
Or 1, Or 2, / S5d: Immunology and allergy
Ron Crystal
TBC
Or 1, Or 2
10:30-11:30 / ESGCT PLENARY SESSION 6
Gene Therapy in the market
GSK
Alessandro Aiuti, Sol Ruiz, Jonathan Appleby, Julie Venners-Christensen
Auditorium
11:30-12:00 / COFFEE BREAKPalazzo Congressi
12:00-13:30 / ESGCT PLENARY SESSION 7
In vivo Gene Therapy
Biogen
Alberto Auricchio, Mark Kay
Auditorium
13:00- 14:00 / LUNCHPalazzo Congressi
14:00-15:30 / S6a: Immunology/ Cancer Immuno Gene Therapy I
Dirk Busch
Bernhard Gentner
Or 1, Or 2 / S6b: Gene Silencing: from small non-coding RNAs to epigenetic editing and gene disruption
Michael Holmes
Frank Slack
Or 1, Or 2 / S6c: Manufacturing of cell and gene therapy products
Molmed
Ian Johnston
Paolo Rizzardi
Or 1, Or 2 / S6d: CNS Gene Therapy: Huntington
Nathalie Cartier
TBC
Or 1, Or 2
15:30-17:00 / PRESIDENTIAL SYMPOSIUM AWARDS CEREMONY
Chairs:Nathalie Cartier-Lacave, ESGCT president; Luigi Naldini, LOC president
PRESIDENTIAL CONFERENCE / ESGCT AGM
George Daley
Amit Nathwani(Outstanding Achievement Award)
TBA (Young Investigator Award)
17:00-18:30 / Germline Editing Debate
Chairs:Nathalie Cartier-Lacave, ESGCT president; Luigi Naldini, LOC president
Panel: Editor of Embo (Roberto Buccione)
George Daley, Feng Zhang, Luigi Naldini, Nathalie Cartier, Annelien Bredenoord,UK panelist
18:30-19:00 / Closing drinks